China SXT Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 |
|---|---|
Revenue | $414 |
Gross Profit | 67 |
EBITDA | -284 |
EBIT | -319 |
Net Income | -401 |
Net Change In Cash | 414 |
Free Cash Flow | -678 |
Cash | 18,512 |
Basic Shares | 403 |
Annual Financials
| Values in thousands | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
Revenue | $1,740 | $1,928 | $1,971 | $2,602 |
Gross Profit | 367 | 553 | 426 | 1,251 |
EBITDA | -2,573 | -2,351 | -5,207 | -5,051 |
EBIT | -2,655 | -2,554 | -5,457 | -5,371 |
Net Income | -3,303 | -3,098 | -5,934 | -5,736 |
Net Change In Cash | 1,740 | 1,928 | 1,971 | 2,602 |
Free Cash Flow | -2,347 | -1,935 | -151 | 205 |
Cash | 18,099 | 12,070 | 17,368 | 15,524 |
Basic Shares | 403 | 867 | 266 | 41 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$1.02 |
2024-12-31 | -$1.99 |
2022-06-30 | -$2.03 |
2021-12-31 | -$0.20 |
